Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/11/2011 → 31/10/2015 |
Funding
- EC European Commission: £40,728.80
Pharmacogenomic biomakers as clinical decision making tools for clozapine treatment of schizophrenia. CRESTAR.
- Curran, Sarah (Primary Investigator)
Project: Research